Image

Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients

Study of Genetic Defects in Neuroendocrine Neoplasms among Mexican Patients

Recruiting
18 years and older
All
Phase N/A

This study investigates neuroendocrine neoplasms (NENs).

The study evaluates the genetic defects related to NENs in Mexican patients.

  • Who can participate: Adults aged 18 years and older with a diagnosis of neuroendocrine neoplasms, including both isolated and familial cases, are eligible. Participants must provide informed consent.
  • Study details: Participants will provide blood and possibly tissue samples for genetic testing.
  • Study timelines: The study will last 15 years.
Study details
    Neuroendocrine Neoplasm
    Neuroendocrine Neoplasm of Gastrointestinal Tract
    Neuroendocrine Neoplasm of Lung
    Thymic Neuroendocrine Neoplasm
    Neuroendocrine Tumor of Pancreas
    Gastrointestinal Stromal Tumors
    Medullary Thyroid Cancer
    Paraganglioma
    Pheochromocytoma
    Primary Hyperparathyroidism
    Pituitary Tumor
    Multiple Endocrine Neoplasia Type 1
    Multiple Endocrine Neoplasia Type 2
    Multiple Endocrine Neoplasia Type 4
    Carney Complex
    Carney Stratakis Dyad
    Carney Triad
    Cowden Syndrome
    DICER1 Syndrome
    Li-Fraumeni Syndrome
    Lynch Syndrome
    Von Hippel-Lindau Disease
    Familial Isolated Pituitary Adenoma
    X-Linked Acrogigantism
    Neurofibromatosis 1
    Tuberous Sclerosis

NCT06523582

Universidad Nacional Autonoma de Mexico

8 April 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.